Treatment and Diagnosis of MOG-Associated Disorders in Pediatric vs Adult: E. Ann Yeh, MD
BTK Inhibitor Fenebrutinib Demonstrates Long-Term Suppression of MS Activity in Open-Label Extension
Hypertension Awareness Gaps in Patients With Multiple Sclerosis: Michael Robers, MD, MS
Wearing Off Rates Higher in Ocrelizumab Than Ofatumumab, Study Suggests